Clinical Research in Cardiology

, Volume 102, Issue 6, pp 439–445

Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients

  • Solmaz Assa
  • Ron T. Gansevoort
  • Ralf Westerhuis
  • Anneke C. Muller Kobold
  • Adriaan A. Voors
  • Paul E. de Jong
  • Stephan J. L. Bakker
  • Casper F. M. Franssen
Original Paper

Abstract

Background

Previous studies using conventional cTnI assays reported conflicting results on the evolution of cTnI levels during hemodialysis. The determinants and prognostic significance of changes in cTnI during hemodialysis are presently unknown. The aim of this prospective study was to characterize the determinants and prognostic significance of intra-dialysis changes in cTnI using a sensitive assay.

Methods

cTnI was measured before and after hemodialysis with a sensitive assay in 90 chronic patients without acute cardiac symptoms. Multivariable regression analyses were used to identify factors that were associated with intra-dialysis rise in cTnI. The prognostic effect of an intra-dialysis rise in cTnI during a 52-month follow-up was evaluated using Cox regression models. The primary and secondary endpoint was the incidence of major adverse cardiovascular events and all-cause mortality, respectively.

Results

Pre-dialysis cTnI was elevated in 31 patients (34 %). cTnI increased significantly during dialysis and this had a trend to be associated with longer dialysis vintage. A greater intra-dialysis rise in cTnI was associated with a significantly higher incidence of cardiovascular events, also after correction for age, gender, dialysis vintage, residual diuresis, previous cardiovascular events, and pre-dialysis cTnI levels (HR per 10 ng/L rise in cTnI: 1.21; CI 1.06–1.38; p 0.005).

Conclusion

TnI levels rise significantly during hemodialysis and a greater intra-dialysis rise in cTnI is associated with an increased incidence of cardiovascular events. These findings suggest that hemodialysis has an acute deleterious effect on the heart. An intra-dialysis rise in cTnI may help identify patients who are susceptible to the hemodynamic stress of hemodialysis.

Keywords

Cardiac troponin I Cardiovascular Hemodialysis Sensitive assay Outcome 

References

  1. 1.
    Troyanov S, Ly QH, Schampaert E, Ammann H, Lalumiere G, Madore F, Querin S (2005) Diagnostic specificity and prognostic value of cardiac troponins in asymptomatic chronic haemodialysis patients: a three year prospective study. Heart 91:1227–1228PubMedCrossRefGoogle Scholar
  2. 2.
    Wang AY, Lai KN (2008) Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol 19:1643–1652PubMedCrossRefGoogle Scholar
  3. 3.
    Wayand D, Baum H, Schatzle G, Scharf J, Neumeier D (2000) Cardiac troponin T and I in end-stage renal failure. Clin Chem 46:1345–1350PubMedGoogle Scholar
  4. 4.
    Apple FS, Murakami MM, Pearce LA, Herzog CA (2002) Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 106:2941–2945PubMedCrossRefGoogle Scholar
  5. 5.
    Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A (2005) Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 112:3088–3096PubMedCrossRefGoogle Scholar
  6. 6.
    Gaiki MR, Devita MV, Michelis MF, Panagopoulos G, Rosenstock JL (2012) Troponin I as a prognostic marker of cardiac events in asymptomatic hemodialysis patients using a sensitive troponin I assay. Int Urol Nephrol 44(6):1841–1845PubMedCrossRefGoogle Scholar
  7. 7.
    Dasselaar JJ, Slart RH, Knip M, Pruim J, Tio RA, McIntyre CW, de Jong PE, Franssen CF (2009) Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant 24:604–610PubMedCrossRefGoogle Scholar
  8. 8.
    McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker CS, Camici PG (2008) Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 3:19–26PubMedCrossRefGoogle Scholar
  9. 9.
    Tun A, Khan IA, Win MT, Hussain A, Hla TA, Wattanasuwan N, Vasavada BC, Sacchi TJ (1998) Specificity of cardiac troponin I and creatine kinase-MB isoenzyme in asymptomatic long-term hemodialysis patients and effect of hemodialysis on these cardiac markers. Cardiology 90:280–285PubMedCrossRefGoogle Scholar
  10. 10.
    Farkouh ME, Robbins MJ, Zafar MU, Shimbo D, Davidson KW, Puttappa R, Winston J, Halperin JL, Epstein EM, Patel M, Talor Z, Chesebro JH (2003) Association between troponin I levels and mortality in stable hemodialysis patients. Am J Med 114:224–226PubMedCrossRefGoogle Scholar
  11. 11.
    Deleaval P, Descombes E, Magnin JL, Martin PY, Fellay G (2006) Differences in cardiac troponin I and T levels measured in asymptomatic hemodialysis patients with last generation immunoassays. Nephrol Ther 2:75–81PubMedCrossRefGoogle Scholar
  12. 12.
    Lippi G, Tessitore N, Montagnana M, Salvagno GL, Lupo A, Guidi GC (2008) Influence of sampling time and ultrafiltration coefficient of the dialysis membrane on cardiac troponin I and T. Arch Pathol Lab Med 132:72–76PubMedGoogle Scholar
  13. 13.
    Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361:858–867PubMedCrossRefGoogle Scholar
  14. 14.
    Reiter M, Twerenbold R, Reichlin T, Benz B, Haaf P, Meissner J, Hochholzer W, Stelzig C, Freese M, Heinisch C, Balmelli C, Drexler B, Freidank H, Winkler K, Campodarve I, Gea J, Mueller C (2012) Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J 33(8):988–997PubMedCrossRefGoogle Scholar
  15. 15.
    Konno T, Shimizu M, Ino H, Fujino N, Hayashi K, Uchiyama K, Kaneda T, Inoue M, Fujita T, Masuta E, Funada A, Mabuchi H (2005) Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic cardiomyopathy in a genotyped population. Am J Cardiol 96:1308–1312PubMedCrossRefGoogle Scholar
  16. 16.
    Iliou MC, Fumeron C, Benoit MO, Tuppin P, Courvoisier CL, Calonge VM, Moatti N, Buisson C, Jacquot C, Chronic Haemodialysis and New Cardiac Markers Evaluation (CHANCE) Study (2001) Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: chronic haemodialysis and new cardiac markers evaluation (CHANCE) study. Nephrol Dial Transplant 16:1452–1458PubMedCrossRefGoogle Scholar
  17. 17.
    Conway B, McLaughlin M, Sharpe P, Harty J (2005) Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis. Nephrol Dial Transplant 20:2759–2764PubMedCrossRefGoogle Scholar
  18. 18.
    Metra M, Bettari L, Pagani F, Lazzarini V, Lombardi C, Carubelli V, Bonetti G, Bugatti S, Parrinello G, Caimi L, Felker GM, Dei Cas L (2012) Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation. Clin Res Cardiol 101:663–672PubMedCrossRefGoogle Scholar
  19. 19.
    Mueller M, Celik S, Biener M, Vafaie M, Schwoebel K, Wollert KC, Januzzi JL, Katus HA, Giannitsis E (2012) Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome. Clin Res Cardiol 101:837–845PubMedCrossRefGoogle Scholar
  20. 20.
    Celik S, Giannitsis E, Wollert KC, Schwobel K, Lossnitzer D, Hilbel T, Lehrke S, Zdunek D, Hess A, Januzzi JL, Katus HA (2011) Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy. Clin Res Cardiol 100:1077–1085PubMedCrossRefGoogle Scholar
  21. 21.
    Beciani M, Tedesco A, Violante A, Cipriani S, Azzarito M, Sturniolo A, Splendiani G (2003) Cardiac troponin I (2nd generation assay) in chronic haemodialysis patients: prevalence and prognostic value. Nephrol Dial Transplant 18:942–946PubMedCrossRefGoogle Scholar
  22. 22.
    Kumar N, Michelis MF, DeVita MV, Panagopoulos G, Rosenstock JL (2011) Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay. Nephrol Dial Transplant 26:665–670PubMedCrossRefGoogle Scholar
  23. 23.
    Ritz E, Rambausek M, Mall G, Ruffmann K, Mandelbaum A (1990) Cardiac changes in uraemia and their possible relationship to cardiovascular instability on dialysis. Nephrol Dial Transplant 5(Suppl 1):93–97PubMedGoogle Scholar
  24. 24.
    McIntyre CW (2009) Effects of hemodialysis on cardiac function. Kidney Int 76:371–375PubMedCrossRefGoogle Scholar
  25. 25.
    Assa S, Dasselaar JJ, Slart RH, de Jong PE, Voors AA, Tio RA, Franssen CF (2012) Comparison of cardiac positron emission tomography perfusion defects during stress induced by hemodialysis versus adenosine. Am J Kidney Dis 59:862–864PubMedCrossRefGoogle Scholar
  26. 26.
    Burton JO, Jefferies HJ, Selby NM, McIntyre CW (2009) Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 4:914–920PubMedCrossRefGoogle Scholar
  27. 27.
    Assa S, Hummel YM, Voors AA, Kuipers J, Westerhuis R, de Jong PE, Franssen CF (2012) Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance. Clin J Am Soc Nephrol 7:1615–1623PubMedCrossRefGoogle Scholar
  28. 28.
    Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MM (2009) Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem 55:930–937PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Solmaz Assa
    • 1
    • 2
  • Ron T. Gansevoort
    • 1
  • Ralf Westerhuis
    • 2
  • Anneke C. Muller Kobold
    • 3
  • Adriaan A. Voors
    • 4
  • Paul E. de Jong
    • 1
  • Stephan J. L. Bakker
    • 1
  • Casper F. M. Franssen
    • 1
  1. 1.Division of Nephrology, Department of Internal MedicineUniversity Medical Center GroningenGroningenThe Netherlands
  2. 2.Dialysis Center GroningenUniversity Medical Center GroningenGroningenThe Netherlands
  3. 3.Department of Laboratory MedicineUniversity Medical Center GroningenGroningenThe Netherlands
  4. 4.Department of CardiologyUniversity Medical Center GroningenGroningenThe Netherlands

Personalised recommendations